Title : Efficacy and safety of fosaprepitant for the prevention of nausea and emesis during 5 weeks of chemoradiotherapy for cervical cancer (the GAND-emesis study): a multinational, randomised, placebo-controlled, double-blind, phase 3 trial.

Pub. Date : 2016 Apr

PMID : 26952945






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 INTERPRETATION: To our knowledge, this is the first study to investigate safety and efficacy of a NK-1 receptor antagonist during 5 weeks of radiotherapy and concomitant weekly cisplatin. Cisplatin tachykinin receptor 1 Homo sapiens